SARS-CoV-2 Coronavirus and COVID-19
FluoroType® SARS-CoV-2 plus | Bruker
SARS Coronavirus Spike (C-term) - The Native Antigen Company
Coronaviruses Have Been Around For Centuries: What Differentiates COVID-19? – Consult QD
How Dangerous Is the Delta Variant (B.1.617.2)?
The mysterious disappearance of the first SARS virus, and why we need a vaccine for the current one but didn't for the other
NIH researchers identify key genomic features that could differentiate SARS- CoV-2 from other coronaviruses that cause less severe disease | National Institutes of Health (NIH)
NIH scientists identify mechanism that may influence infectivity of SARS-CoV-2 variants | National Institutes of Health (NIH)
Virus Pathogen Database and Analysis Resource (ViPR) - Coronaviridae - Genome database with visualization and analysis tools
History of SARS/MERS: Outbreaks and vaccine timeline
SARS-CoV-2: Still More Questions than Answers
A Visual Guide to the SARS-CoV-2 Coronavirus - Scientific American
SARS-Cov-2 Initial Origin | Amelia Heart & Vascular Center
Why some individuals have stronger SARS-COV-2 defences – UKRI
Diagnostics | Free Full-Text | Laboratory Diagnosis of SARS-CoV-2 Pneumonia
SARS-CoV-2: What's in a Name?
Why does SARS-CoV-2 spread so easily?
Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant | UC San Francisco
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review | Molecular Cancer | Full Text
coronavirus | Definition, Features, & Examples | Britannica
An Update on the Perioperative Considerations for COVID-19 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Anesthesia Patient Safety Foundation
SARS-CoV-2 triggers antibodies from previous coronavirus infections
SARS Coronavirus Nucleoprotein N-Term - The Native Antigen Company
